However, of those genes included in the pPRS score, prior evidence links NSAID anti-cancer activity with β-catenin (CTNNB134–37), GNAS38, and PTGER419, the extracellular receptor for PGE2, the major downstream prostanoid produced by PTGS-2. This evidence concerns the gene PTGS2 and cancer.